RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% Trademark

Trademark Overview

On Wednesday, September 26, 2018, a trademark application was filed for RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% with the United States Patent and Trademark Office. The USPTO has given the RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% trademark a serial number of 88132387. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, April 25, 2025. This trademark is owned by Aerie Pharmaceuticals, Inc.. The RHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02% trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations containing Netarsudil for the treatment of glaucoma and ocular hypertension
rhopressa (netarsudil ophthalmic solution) 0.02%

General Information

Serial Number88132387
Word MarkRHOPRESSA (NETARSUDIL OPHTHALMIC SOLUTION) 0.02%
Filing DateWednesday, September 26, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, April 25, 2025
Registration Number5785832
Registration DateTuesday, June 25, 2019
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 9, 2019

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicespharmaceutical preparations containing Netarsudil for the treatment of glaucoma and ocular hypertension
Description of MarkThe mark consists of THE WORD "RHOPRESSA" WITH THE WORDS "(NETARSUDIL OPHTHALMIC SOLUTION) 0.02%" BENEATH "RHOPRESSA".
NOT AVAILABLE"(NETARSUDIL OPHTHALMIC SOLUTION) 0.02%"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 4, 2018
Primary Code005
First Use Anywhere DateTuesday, March 13, 2018
First Use In Commerce DateTuesday, March 13, 2018

Trademark Owner History

Party NameALCON INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFribourg CH-1701
CH
Party NameAerie Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921

Trademark Events

Event DateEvent Description
Saturday, September 29, 2018NEW APPLICATION ENTERED
Thursday, October 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 8, 2019ASSIGNED TO EXAMINER
Thursday, January 10, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, January 10, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, January 10, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 10, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, January 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 29, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 29, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 7, 2019ASSIGNED TO LIE
Tuesday, February 26, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, March 4, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, March 7, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, March 7, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, March 7, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 7, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, March 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, March 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 25, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, January 10, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, April 25, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 25, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 25, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, November 21, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 21, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 21, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

solution ophthalmic netarsudil rhopressa glaucoma ocular hypertension treatment preparations containing pharmaceutical